ChemoCentryx, Inc.
HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES
Last updated:
Abstract:
Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) ##STR00001## including stereoisomers and pharmaceutically acceptable salts thereof, wherein R.sup.2a, R.sup.2b, R.sup.3, R.sup.3a, R.sup.4, R.sup.6, R.sup.7, R.sup.8, A, Z, X.sup.1 and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Status:
Application
Type:
Utility
Filling date:
15 Oct 2020
Issue date:
6 May 2021